Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 164, Issue 2, 2012, Pages 161-166

  Gateva, Antoaneta Trifonova ^a   Kamenov, Zdravko Asenov ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Anthropometric markers; Cardiovascular risk; PCOS

Indexed keywords

ANDROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANDROGEN BLOOD LEVEL; ANDROGEN EXCESS AND POLYCYSTIC OVARY SYNDROME SOCIETY CONSENSUS; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO STATURE RATIO;

EID: 84866732383     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2012.05.037     Document Type: Article

References (38)

1. M. Asuncion, R.M. Calvo, J.L. San Millan, J. Sancho, S. Avila, and H.F. Escobar-Morreale A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain Journal of Clinical Endocrinology and Metabolism 85 2000 2434 2438
2. E.S. Knochenhauer, T.J. Key, M. Kahsar-Miller, W. Waggoner, L.R. Boots, and R. Azziz Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study Journal of Clinical Endocrinology and Metabolism 83 1998 3078 30824
3. D.A. Ehrmann, R.B. Barnes, R.L. Rosenfield, M.K. Cavaghan, and J. Imperial Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome Diabetes Care 22 1999 141 146
4. R.S. Legro, A.R. Kunselman, W.C. Dodson, and A. Dunaif Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women Journal of Clinical Endocrinology and Metabolism 84 1999 165 1695
5. J. Vrbikova, R. Cifkova, and A. Jirkovska Cardiovascular risk factors in young Czech females with polycystic ovary syndrome Human Reproduction 18 2003 980 984
6. E. Talbott, D. Guzick, and A. Clerici Coronary heart disease risk factors in women with polycystic ovary syndrome Arteriosclerosis, Thrombosis, and Vascular Biology 15 1995 821 826
7. R.A. Wild, P. Alaupovic, and I.J. Parker Lipid and apolipoprotein abnormalities in hirsute women: the association with insulin resistance American Journal of Obstetrics and Gynecology 166 1992 1191 1196
8. R.A. Wild Obesity, lipids, cardiovascular risk, and androgen excess American Journal of Medicine 98 1995 27S 32S
9. G. Paradisi, H.O. Steinberg, and A. Hempfling Polycystic ovary syndrome is associated with endothelial dysfunction Circulation 103 10 2001 1410 1415
10. K. Lakhani, N. Constantinovici, and W.M. Purcell Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries Lancet 356 2000 1166 1167
11. C.J. Kelly, A. Speirs, and G.W. Gould Altered vascular function in young women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 87 2002 742 746
12. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population Journal of Clinical Endocrinology and Metabolism 89 2004 2745 2749
13. A.H. Balen, G.S. Conway, and G. Kaltsas Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients Human Reproduction 10 1995 2107 2111
14. C.J. Glueck, S. Dharashivkar, and P. Wang Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy European Journal of Obstetrics, Gynecology, and Reproductive Biology 122 2 2005 206 212
15. T. Apridonidze, P.A. Essah, M.J. Iuorno, and J.E. Nestler Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 90 2005 1929 1935
16. T. Douchi, H. Ijuin, S. Nakamura, T. Oki, S. Yamamoto, and Y. Nagata Body fat distribution in women with polycystic ovary syndrome Obstetrics and Gynecology 86 1995 516 519
17. P. Acien, F. Quereda, and P. Matallin Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders Fertility and Sterility 72 1 1999 32 40
18. J. Lord, R. Thomas, B. Fox, U. Acharya, and T. Wilkin The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome BJOG: An International Journal of Obstetrics and Gynaecology 113 2006 1203 1209
19. J.J. Puder, S. Varga, M. Kraenzlin, C. De Geyter, U. Keller, and B. Müller Central fat excess in polycystic ovary syndrome: relation with low-grade inflammation and insulin resistance The Journal of Clinical Endocrinology and Metabolism 90 2005 6014 6021
20. T.P. Ciaraldi, A.J. Morales, and M.G. Hickman Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity Journal of Clinical Endocrinology and Metabolism 82 1997 1421 1425
21. I. Ek, P. Arner, and A. Bergqvist Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance? Journal of Clinical Endocrinology and Metabolism 82 1997 1147 1153
22. T. Cascella, S. Palomba, and I. De Sio Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome Human Reproduction 23 2008 153 159
23. P. Bjorntorp The associations between obesity, adipose tissue distribution and disease Acta Medica Scandinavica 723 1988 121 134
24. L.M. Browning, S.D. Hsieh, and M. Ashwell A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value Nutrition Research Reviews 23 2010 247 269
25. C.M. Lee, R.R. Huxley, R.P. Wildman, and M. Woodward Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis Journal of Clinical Epidemiology 61 2008 646 653
26. L.N. Matos, V. Giorelli Gde, and C.B. Dias Correlation of anthropometric indicators for identifying insulin sensitivity and resistance Sao Paulo Medical Journal 6 1291 2011 30 35
27. Rotterdam ESHRE/ASRM-sponsored Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovarian syndrome Fertility and Sterility 81 1 2004 19 25
28. World Health Organisation Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee WHO Organisation Technical Report Series 854 1995 1 452
29. A. Chobanian, G. Barkis, and H. Black Seventh report of the Joint Committee on prevention, detection, evaluation and treatment of high blood pressure Hypertension 42 2003 1206 1252
30. Tolonen H, Kuulasimaa K, Laatikanien T, Wolf H. European Health Risk Monitoring (EHRM). Recommendation for indicators, international collaboration, protocol and manual of operations for chronic disease risk factor surveys. 2002 URL: http://www.ktl.fi/publications/ehrm/product2/title.htm.
31. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
32. K. Alberti, R. Eckel, and S. Grundy Harmonizing the metabolic syndrome. A Joint Interim Statement of the IDF Task Force on Epidemiology and Prevention, NHLBI, AHA, WHF, International Atherosclerosis Society and International Association for Study of Obesity Circulation 120 2009 1640 1645
33. R.A. Wild, E. Carmina, and E.D. Kandarakis Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society The Journal of Clinical Endocrinology and Metabolism 95 2010 2038 2049
34. S. Yusuf, S. Hawken, and S. Ounpuu Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
35. K.M. Knowles, L. Paiva, and S.E. Sanchez Waist Circumference. Body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults International Journal of Hypertension 2011 2011 931402
36. K.G. Alberti, P. Zimmet, J. Shaw IDF Epidemiology Task Force Consensus Group The metabolic syndrome: a new worldwide definition Lancet 366 2005 1059 1062
37. I. Graham, D. Atar, and K. Borch-Johnsen ESC Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention inclinical practice: executive summary Atherosclerosis 194 2007 1 45
38. World Health Organization Obesity: Preventing and Managing the Global Epidemic: Report on a WHO Consultation (WHO Technical Report Series 894) 2000 World Health Organization Geneva, Switzerland